Species differences in the pharmacokinetics of KW-7158 [(2S)-(+)-3,3,3-Trifluoro-2-hydroxy-2-methyl-N-(5,5,10-trioxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)propanamide]: formation of hydrolyzed metabolite in human and animals

References

• Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.
   PubMed Web of Science ®Google Scholar
• Cheng CL, Ma CP, de Groat WC. (1995). Effect of capsaicin on micturition and associated reflexes in chronic spinal rats. Brain Res 678:40–48.
   PubMedGoogle Scholar
• Chiba M, Hensleigh M, Lin JH. (1997). Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A. Biochem Pharmacol 53:1187–1195.
   PubMed Web of Science ®Google Scholar
• Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–1095.
   PubMed Web of Science ®Google Scholar
• Fujita K, Sparreboom A. (2010). Pharmacogenetics of irinotecan disposition and toxicity: A review. Curr Clin Pharmacol 5:209–217.
   PubMedGoogle Scholar
• Komura H, Yasuda M, Yoshida NH, Sugiyama Y. (2002). Species difference in nisoldipine oxidation activity in the small intestine. Drug Metab Pharmacokinet 17:427–436.
   PubMedGoogle Scholar
• He G, Massarella J, Ward P. (1999). Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet 37:471–484.
   PubMed Web of Science ®Google Scholar
• He K, Talaat RE, Pool WF, Reily MD, Reed JE, Bridges AJ, Woolf TF. (2004). Metabolic activation of troglitazone: Identification of a reactive metabolite and mechanisms involved. Drug Metab Dispos 32:639–646.
   PubMed Web of Science ®Google Scholar
• Imai T. (2006). Human carboxylesterase isozymes: Catalytic properties and rational drug design. Drug Metab Pharmacokinet 21:173–185.
   PubMed Web of Science ®Google Scholar
• Inoue T, Nitta K, Sugihara K, Horie T, Kitamura S, Ohta S. (2008). CYP2C9-catalyzed metabolism of S-warfarin to 7-hydroxywarfarin in vivo and in vitro in chimeric mice with humanized liver. Drug Metab Dispos 36:2429–2433.
   PubMed Web of Science ®Google Scholar
• Kamimura H, Nakada N, Suzuki K, Mera A, Souda K, Murakami Y, Tanaka K, Iwatsubo T, Kawamura A, Usui T. (2010). Assessment of chimeric mice with humanized liver as a tool for predicting circulating human metabolites. Drug Metab Pharmacokinet 25:223–235.
   PubMed Web of Science ®Google Scholar
• Kirimura K, Furuya T, Sato R, Ishii Y, Kino K, Usami S. (2002). Biodesulfurization of naphthothiophene and benzothiophene through selective cleavage of carbon-sulfur bonds by Rhodococcus sp. strain WU-K2R. Appl Environ Microbiol 68:3867–3872.
   PubMed Web of Science ®Google Scholar
• Lu SH, Yamagata T, Atsuki K, Sun L, Smith CP, Yoshimura N, Chancellor MB, de Groat WC. (2002). Effect of KW-7158, a putative afferent nerve inhibitor, on bladder and vesico-vascular reflexes in rats. Brain Res 946:72–78.
   PubMed Web of Science ®Google Scholar
• Malmgren A, Andersson KE, Sjögren C, Andersson PO. (1989). Effects of pinacidil and cromakalim (BRL 34915) on bladder function in rats with detrusor instability. J Urol 142:1134–1138.
   PubMed Web of Science ®Google Scholar
• Mohri K, Uesawa Y, Sagawa K. (2000). Effects of long-term grapefruit juice ingestion on nifedipine pharmacokinetics: Induction of rat hepatic P-450 by grapefruit juice. Drug Metab Dispos 28:482–486.
   PubMed Web of Science ®Google Scholar
• Pacifici GM, Franchi M, Bencini C, Repetti F, Di Lascio N, Muraro GB. (1988). Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica 18:849–856.
   PubMed Web of Science ®Google Scholar
• Saito M, Longhurst PA, Tammela TL, Wein AJ, Levin RM. (1993). Effects of partial outlet obstruction of the rat urinary bladder on micturition characteristics, DNA synthesis and the contractile response to field stimulation and pharmacological agents. J Urol 150:1045–1051.
   Google Scholar
• Satoh T, Hosokawa M. (1998). The mammalian carboxylesterases: From molecules to functions. Annu Rev Pharmacol Toxicol 38:257–288.
   PubMed Web of Science ®Google Scholar
• Satoh T, Taylor P, Bosron WF, Sanghani SP, Hosokawa M, La Du BN. (2002). Current progress on esterases: From molecular structure to function. Drug Metab Dispos 30:488–493.
   PubMed Web of Science ®Google Scholar
• Shibasaki M, Crandall CG. (2001). Effect of local acetylcholinesterase inhibition on sweat rate in humans. J Appl Physiol 90:757–762.
   PubMed Web of Science ®Google Scholar
• Slatter JG, Su P, Sams JP, Schaaf LJ, Wienkers LC. (1997). Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions. Drug Metab Dispos 25:1157–1164.
   PubMed Web of Science ®Google Scholar
• United States Food and Drug Administration (US-FDA). (2001) Guidance for Industry: Bioanalytical Method Validation.
   Google Scholar
• Yamagata T, Atsuki K, Ohno T, Shirakura S, de Groat WC, Sculptoreanu A, Karasawa A, Yoshimura N. (2002). International Patent Application. WO02/078523.
   Google Scholar
• Yoshida M, Seishi T, Aono S, Takai H, Suzuki K, Yamagata T, Atsuki K, Karasawa A, Kumazawa T. (1998). International Patent Application. WO98/46587.
   Google Scholar
• Yoshigae Y, Imai T, Taketani M, Otagiri M. (1999). Characterization of esterases involved in the stereoselective hydrolysis of ester-type prodrugs of propranolol in rat liver and plasma. Chirality 11:10–13.
   PubMed Web of Science ®Google Scholar